New Research Finds Challenges in Symptom Recognition and Diagnostic Testing can impact Patient Satisfaction for People with Vascular Disease

0

Abbott today released new global market research from its Beyond Intervention initiative, the company’s multi-year global research program designed to examine the vascular patient experience from the perspectives of patients, physicians and healthcare leaders. The latest research focuses on challenges that arise for physicians and patients during the earliest stages of the patient journey, uncovering new opportunities for health systems and hospitals to leverage technology, break down existing barriers and improve patient care.

The findings from Beyond Intervention identify several key areas for improvement related to the diagnosis and treatment of cardiovascular disease. These include reducing inconsistencies in patient care delivery, improving access to technology to support accurate diagnosis, and addressing issues of health equity that result in inadequate care for underserved communities. The report also underscores the differences in how patients and healthcare providers perceive the effectiveness of the care being delivered.

“The latest data from the Beyond Intervention initiative reveals diverging views between patients and healthcare administrators on how each views the patient experience and the impact of inequities across the healthcare continuum,” said Nick West M.D., chief medical officer and divisional vice president of medical affairs at Abbott’s vascular business. “This research solidifies the need for physicians to leverage innovative technologies to improve the ability to make and communicate a diagnosis as early as possible in the patient journey.”

See also  All above 18 years to get free COVID-19 vaccine in Delhi, says Kejriwal